December 17, 2010
New study contradicts presence of oxysterols in multiple sclerosis patients
- /
Dec 16, 2010 New research findings appearing in the January Journal of Lipid Researchindicate that compounds called oxysterols are not present…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
December 17, 2010
Stress and MS: Relaxation Techniques
- /
- /
The National MS Society and MS Learn Online present… A new Feature Presentation: Stress and MS: Relaxation Techniques A video webcast that explores… Is…
December 14, 2010
A RESEARCH STUDY (on dysphagia) for the MS Patient and THEIR Caregiver(s)
- /
A study is being conducted to investigate the symptoms of dysphagia, or swallowing disorders, in people with MS. · Dysphagia…
December 14, 2010
The human body can create its own vaccine, which boosts the immune system and helps prevent chronic inflammatory diseases
- /
- /
Vaccine Boosts Your Immune System ScienceDaily (Dec. 14, 2010) — Researchers at BRIC, the University of Copenhagen, have discovered that the…
December 14, 2010
THE Myelin Repair Foundation’s response to: Promoting Remyelination in Humans
- /
- /
- /
by SCOTT JOHNSON on DECEMBER 14, 2010 As you might imagine, we’ve heard from many of you about the latest news from the…
December 14, 2010
2010 – a Significant Year for those affected by Multiple Sclerosis
- /
- /
- /
1) MS Views and News – launches it’s first educational seminar in February – a Spanish language program, the first…
December 14, 2010
Futility of the autoimmune orthodoxy in multiple sclerosis research
- /
- /
Information provided By Sharon Salem 2010 Expert-Reviews, LTD. “Experimental allergic encephalomyelitis is … a true autoimmune disorder. It has been…
December 14, 2010
With the Recent Launch of Novartis’s Gilenya, Extavia is Pushed Into the Background of Multiple Sclerosis Treatment
- /
- /
EXTON, Pa., Dec. 13, 2010 /PRNewswire/ — BioTrends Research Group, Inc. finds that with the introduction of Novartis’ Gilenya, the first oral disease-modifying…
December 10, 2010
Lipoatrophy, Mitoxantrone for Secondary Progressive Multiple Sclerosis, and more – from International Journal of MS Care – Winter Issue
- /
- /
Information provided by: Cherie C. Binns RN BS MSCN http://www.mscare.org/cmsc/Current-Issue.html Here is the listing of this issue’s contents. Editorial Lael…
December 9, 2010
Teva multiple sclerosis pill shines in big study
- /
- /
Thu Dec 9, 2010 1:27pm GMT * Teva hopes for U.S. regulatory green light in 2 years * Teva developing…
